Contact Jacoby & Meyers
Dangerous Drug Lawyers
Call us Today 800-977-5614

Relafen is classified as a nonsteroidal anti-inflammatory drug (NSAID). NSAIDs work to reduce the hormones in the body which cause inflammation and pain. Relafen is prescribed to treat the pain and inflammation associated with arthritis. It is manufactured by SmithKline Beecham and was approved by the FDA in 2001.
Relafen has been associated with serious side effects, especially if taken while pregnant. This drug has been seen to cause birth defects when taken late in pregnancy. In one study, researchers found that newborns exposed to Relafen in the womb were 30-80 percent more likely to be born with a cleft lip or palate. Other side effects that have been seen in newborns include clubfoot, amniotic band syndrome, birth defects of the eyes and spina bifida.
Relafen has also been linked to the serious and sometimes fatal skin disease Stevens Johnson syndrome. This disease can cause skin rash, peeling and sores on the mucous membranes. If SJS is severe, the skin can actually peel off in large areas of the body.
Serious side effects include:
Less serious side effects may include:
Lawyer Advertising. This website is designed for general information only, and in no way is intended to constitute legal advice nor the formation of a lawyer/client relationship without a signed, written agreement. Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. You pay no fees or costs unless we recover for you. This website contains dramatizations. Prior results are not a guarantee of a future outcome. Jacoby & Meyers does not accept all cases and works cooperatively with co-counsel and/or other law firms with whom it has joint agreements who might potentially handle your cases. We look forward to helping you with your claim.
© 2012-2025 Jacoby & Meyers. All rights reserved.